Labcyte Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
200
- Latest Deal Type
-
M&A
- Investors
-
1
Labcyte General Information
Description
Developer of an acoustic droplet ejection (ADE) technology designed to enhance personalized medicine programs. The company's technology uses acoustic energy to transfer precise amounts of fluids without touching them, which can improve data quality and reliability and focuses on ultrasonic acoustic energy into a fluid sample to eject droplets of liquid from open wells, enabling healthcare industry to streamline DNA/RNA diagnostic testing, optimize drug discovery pipelines and accelerate life science research.
Contact Information
Website
www.labcyte.comCorporate Office
- 170 Rose Orchard Way
- San Jose, CA 95134
- United States
Corporate Office
- 170 Rose Orchard Way
- San Jose, CA 95134
- United States
Labcyte Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 30-Jan-2019 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 01-Nov-2017 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series E) | 03-Jan-2017 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Debt - General | 06-May-2015 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 19-Sep-2013 | Completed | Generating Revenue | |||
| 5. Grant | 09-Nov-2011 | Completed | Generating Revenue | |||
| 4. Mezzanine | 12-Nov-2009 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 13-Mar-2008 | $24.8M | $52.6M | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 09-Jul-2002 | $22.5M | $27.8M | Completed | Startup |
Labcyte Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 28,137,025 | $0.010000 | $0.06 | $0.8 | $0.8 | 1x | $0.8 | 19.56% |
| Series A | 10,277,815 | $0.010000 | $0.04 | $0.54 | $0.54 | 1x | $0.54 | 7.14% |
Labcyte Comparisons
Industry
Financing
Details
Labcyte Competitors (14)
One of Labcyte’s 14 competitors is Eppendorf, a Corporation company based in Hamburg, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eppendorf | Corporation | Hamburg, Germany | ||||
| Hettich | Private Equity-Backed | Tuttlingen, Germany | ||||
| Autogen | Corporation | Holliston, MA | ||||
| Eppendorf India | Corporation | Chennai, India | ||||
| Illumina | Formerly VC-backed | San Diego, CA |
Labcyte Patents
Labcyte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026117585-A1 | Container plate alignment for acoustic droplet ejection | Pending | 26-Nov-2024 | ||
| WO-2026084901-A1 | Acoustic transducer refocusing for uninterrupted acoustic drop ejection | Pending | 14-Oct-2024 | ||
| US-20250166984-A1 | Frequency decoupling in dynamic fluidic analysis and acoustic droplet ejection | Pending | 31-Oct-2023 | ||
| EP-4709532-A1 | Acoustic transducer array assembly | Pending | 12-May-2023 | ||
| WO-2024238394-A1 | Acoustic transducer array assembly | Inactive | 12-May-2023 | B06B1/06 |
Labcyte Signals
Labcyte Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Alloy Ventures | Venture Capital | Minority | ||
| Cross Atlantic Partners | PE/Buyout | Minority | ||
| DBL Partners | Venture Capital | Minority | ||
| Delphi Ventures (California) | Venture Capital | Minority |
Labcyte Acquisitions (3)
Labcyte’s most recent deal was a Merger/Acquisition with EDC Biosystems. The deal was made on 30-Sep-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| EDC Biosystems | 30-Sep-2020 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Allegro Technologies | 27-Jan-2008 | Merger/Acquisition | Medical Supplies | ||
| Picoliter | 04-Nov-2003 | Merger of Equals | Biotechnology |
Labcyte FAQs
-
When was Labcyte founded?
Labcyte was founded in 2000.
-
Where is Labcyte headquartered?
Labcyte is headquartered in San Jose, CA.
-
What is the size of Labcyte?
Labcyte has 200 total employees.
-
What industry is Labcyte in?
Labcyte’s primary industry is Other Devices and Supplies.
-
Is Labcyte a private or public company?
Labcyte is a Private company.
-
What is Labcyte’s current revenue?
The current revenue for Labcyte is .
-
How much funding has Labcyte raised over time?
Labcyte has raised $92M.
-
Who are Labcyte’s investors?
Abingworth, Alloy Ventures, Cross Atlantic Partners, DBL Partners, and Delphi Ventures (California) are 5 of 14 investors who have invested in Labcyte.
-
Who are Labcyte’s competitors?
Eppendorf, Hettich, Autogen, Eppendorf India, and Illumina are some of the 14 competitors of Labcyte.
-
When was Labcyte acquired?
Labcyte was acquired on 30-Jan-2019.
-
Who acquired Labcyte?
Labcyte was acquired by Beckman Coulter.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process